| Application no. and date | 04743983.1 (espacenet) (Federated) (European Patent Register), 20040712 | | Patent/reg. no. and date | DK/EP 1660485, 20061227 | | Publication date | 20060531 | | Priority no. and date | GB 0317229, 20030723 | | EP pub. no. and date |
EP 1660485 20060531 | | Effective date | | | Applicant/owner | Pfizer, Inc., 235 East 42nd Street
New York, NY 10017, US | | Applicant ref. no. | P80603235DK00E | | Inventor | FURLONG, Patrick Joseph, Pfizer Ireland Pharmaceuticals
Ringaskiddy API Plant
Ringaskiddy,CoCork, IE,
KELLY, Cornelius Joseph, Pfizer Ireland Pharmaceuticals
Ringaskiddy API Plant
Ringaskiddy,CoCork, IE,
OGILVIE, Ronald James, Pfizer Global Research and Development
Ramsgate Road
Sandwich,
Kent CT13 9NJ, GB,
RYAN, Vincent, Pfizer Ireland Pharmaceuticals
Ringaskiddy API Plant
Ringaskiddy,CoCork, IE | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | C07D 403/06 (2006.01) | | Title | Forbedret fremgangsmåde til fremstilling af alpha-polymorfisk eletriptanhydrobromid | | Int. application no. | IB2004002322 | | Int. publication no. | WO2005007649 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
